Impact of a selective cyclooxygenase-2 inhibitor, celecoxib, on cortical excitability and electrophysiological properties of the brain in healthy volunteers: A randomized, double-blind, placebo-controlled study
Author:
Funder
Pfizer Inc.
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference26 articles.
1. Celecoxib for the prevention of sporadic colorectal adenomas;MM Bertagnolli;N Engl J Med,2006
2. Innate immunity: the missing link in neuroprotection and neurodegeneration?;MD Nguyen;Nat Rev Neurosci,2002
3. The role of inflammation in epilepsy;A Vezzani;Nat Rev Neurol,2011
4. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy;NP Turrin;Neurobiol Dis,2004
5. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy;B Voutsinos-Porche;Neurobiol Dis,2004
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery;Frontiers in Pharmacology;2024-05-30
2. Exploring the Therapeutic Potential of Quadripulse rTMS over the Visual Cortex: A Proof-of-Concept Study in Healthy Volunteers and Chronic Migraine Patients with Medication Overuse Headache;Biomedicines;2024-01-26
3. Neuroprotective Agents: A Simple Overview;Open Access Macedonian Journal of Medical Sciences;2022-09-02
4. Celecoxib Decrease Seizures Susceptibility in a Rat Model of Inflammation by Inhibiting HMGB1 Translocation;Pharmaceuticals;2021-04-19
5. Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management;Journal of Neuroinflammation;2019-10-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3